Inhibition of virus entry: an antiviral mechanism of emerging prominence

Curr Opin Investig Drugs. 2006 Feb;7(2):106-8.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology*
  • Antiviral Agents / therapeutic use
  • CCR5 Receptor Antagonists
  • Cell Adhesion
  • Drug Design
  • Enfuvirtide
  • HIV / drug effects*
  • HIV / physiology
  • HIV Envelope Protein gp120 / physiology
  • HIV Envelope Protein gp41 / pharmacology
  • HIV Envelope Protein gp41 / therapeutic use
  • HIV Fusion Inhibitors / pharmacology*
  • HIV Fusion Inhibitors / therapeutic use
  • HIV Infections / drug therapy
  • Humans
  • Membrane Fusion
  • Peptide Fragments / pharmacology
  • Peptide Fragments / therapeutic use
  • Piperazines / pharmacology
  • Piperazines / therapeutic use

Substances

  • Antiviral Agents
  • BMS-378806
  • CCR5 Receptor Antagonists
  • HIV Envelope Protein gp120
  • HIV Envelope Protein gp41
  • HIV Fusion Inhibitors
  • Peptide Fragments
  • Piperazines
  • Enfuvirtide